Blue Jays outfielder Addison Barger will undergo season-ending elbow surgery, ending his 2026 campaign after a nine-game stint with a .045 batting average.
Blue Jays manager John Schneider confirmed that Addison Barger’s 2026 season is over after the 26-year-old outfielder will undergo elbow surgery, likely either Tommy John or an internal brace procedure. The decision comes after Barger’s elbow issues, which began a couple of years,
were exacerbated by a 101.2 m.p.h. throw on May 9 that nearly ended the game, according to Sportsnet. That throw kind of aggravated it and got to the point where he wanted to get it fixed,
Schneider said, per the outlet.
A Fractured Season: Injuries and Setbacks
Barger’s 2026 campaign was derailed by a series of injuries. He initially missed 29 games with a left ankle sprain, then returned for one game in May before re-injuring his elbow. A stress reaction in his back further complicated his recovery, leaving him sidelined for the remainder of the season. His statistical slump mirrored his physical struggles: in nine games, Barger batted .045 with a .214 on-base percentage and .091 slugging percentage, a stark contrast to his 2025 season where he hit 21 home runs and posted a .756 OPS, per CBC.
The elbow injury worsened after his high-velocity throw to tag out Jorge Soler at home plate. It’s tough to lose the whole year of at-bats, reps and performance,
Schneider said, adding that the team had counted on him to be a big part of our team.
The manager emphasized the personal and professional frustration of losing a player starting his career and trending in the right direction,
as reported by MLB.com.
The Road to Recovery: Surgery Options and Timeline
Dr. Keith Meister will perform the surgery, with the procedure type—Tommy John or internal brace—determining Barger’s return timeline. A Tommy John surgery typically requires nine months of recovery, while an internal brace could shorten it to six. Both options would keep Barger out of the 2026 season and likely part of 2027, according to Sportsnet and MLB Trade Rumors. If he opts for Tommy John, he might return by late April 2027; a six-month recovery would push his return to mid-2027.
Recent examples like Bryce Harper’s 160-day recovery from Tommy John surgery and Corey Seager’s 11-month rehab offer benchmarks, though Barger’s case differs as a position player. Position players typically return from elbow reconstruction faster than pitchers,
Sportsnet noted, citing Harper’s return as a designated hitter. However, Barger’s throwing intensity and the need for full fielding readiness complicate his timeline.
Impact on the Blue Jays: Roster Moves and Trade Considerations
Barger’s absence adds pressure to an already struggling Blue Jays team, which entered July with a 47-56 record. The club may pursue trades before the August 3 deadline, with players like Daulton Varsho and George Springer—both impending free agents—likely targets. MLB Trade Rumors highlighted that Springer’s 10-and-5 rights could complicate a trade, while Myles Straw’s $8MM club option for next year, with a $1.75MM buyout, makes him a potential trade asset.
Jesús Sánchez, under club control through 2027, could also be moved, though his $6.8MM salary this year complicates negotiations. The Blue Jays may also look to acquire depth, with prospects like Rudy Martin already in the minors. The Jays will now proceed without Barger for the rest of the campaign,
MLB Trade Rumors wrote, noting Kazuma Okamoto will be the regular at third base while the outfield will be more in flux.
A Career in the Balance: What Comes Next?
Barger’s injury underscores the fragility of athletic careers, particularly for young players. His 2025 breakout—highlighted by 21 home runs and a .756 OPS in 135 regular season games, plus three playoff home runs—made him a key figure in the Blue Jays’ plans for 2026. Now, the team must navigate his recovery while managing roster decisions. We were counting on him, obviously, to be a big part of our team,
Schneider said, per MLB.com. It’s frustrating for him and for us.
With the surgery scheduled for Monday, the Blue Jays will focus on stabilizing their lineup and assessing trade options. Barger’s return to full form remains uncertain, but his 2027 availability will shape the team’s long-term strategy. For now, the franchise faces a pivotal stretch as they weigh selling assets or rebuilding around a core that now lacks one of its most promising stars.
Worth a look
